Clinical measures of bullous pemphigoid
10.3760/cma.j.issn.0412-4030.2016.01.023
- VernacularTitle:大疱性类天疱疮临床评估指标的研究进展
- Author:
Yidi LIU
;
Yagang ZUO
;
Li LI
- Publication Type:Journal Article
- Keywords:
Pemphigoid,bullous;
Autoimmunity;
Severity of illness score;
Bullous pemphigoid disease area index;
Clinical outcome measures
- From:
Chinese Journal of Dermatology
2016;49(1):65-68
- CountryChina
- Language:Chinese
-
Abstract:
Bullous pemphigoid (BP) is a group of autoimmune blistering skin diseases.There are special measures for the assessment of disease severity and therapeutic response in autoimmune bullous skin diseases.Common scoring indexes include autoimmune bullous skin disorder intensity score (ABSIS),bullous pemphigoid disease area index (BPDAI),and so on.ABSIS has been validated,and is widely applied in evaluation of pemphigus vulgaris and other autoimmune blistering diseases.BPDAI is still in the process of verification,and has been applied in only a few clinical trials.The evaluation of diseases by ABSIS and BPDAI is both based on a global assessment of skin and mucosal lesions,and degree of subjective pruritus.
